Breast Cancer Drug: Do Risks Outweigh Benefits?

UH Case Medical Center's Dr. Paula Silverman discusses Avastin in breast cancer.
3:00 | 07/20/10

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

More information on this video
Enhanced full screen
Explore related content
Comments
Related Extras
Related Videos
Video Transcript
Transcript for Breast Cancer Drug: Do Risks Outweigh Benefits?

This transcript has been automatically generated and may not be 100% accurate.

{"id":11205906,"title":"Breast Cancer Drug: Do Risks Outweigh Benefits?","duration":"3:00","description":"UH Case Medical Center's Dr. Paula Silverman discusses Avastin in breast cancer.","section":"Health","mediaType":"Default"}